Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Schweighofer, N; Filipič, M; Varda, NM; Cuderman, A; Prevodnik, VK; Talakić, E.
18 F-FDG PET/CT in Rhabdomyosarcoma of the Prostate in an Infant.
Clin Nucl Med. 2026; 51(2): 137-140.
Doi: 10.1097/RLU.0000000000006248
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Talakic Emina
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Rhabdomyosarcoma (RMS) of the prostate is a rare tumor in infants. RMS frequently arises in genitourinary tract (~20% of cases), with the embrional subtype being the most common. 1,2 The presenting symptoms are usually not specific, often leading to an extensive diagnostic work-up before identifying RMS. 3,4 Furthermore, there are no biomarkers specific to RMS. We present the case of a 4-month-old boy with postrenal acute kidney injury (AKI). Abdominal ultrasound and magnetic resonance imaging (MRI), followed by ultrasound-guided fine-needle aspiration biopsy and citopathological examination, established the diagnosis of prostatic RMS, which was later staged with 18 F-FDG PET/CT. 5.
- Find related publications in this database (using NLM MeSH Indexing)
- Humans - administration & dosage
- Male - administration & dosage
- Rhabdomyosarcoma - diagnostic imaging, pathology
- Fluorodeoxyglucose F18 - administration & dosage
- Infant - administration & dosage
- Positron Emission Tomography Computed Tomography - administration & dosage
- Prostatic Neoplasms - diagnostic imaging, pathology